RxDoctor Payments Data

Rachel Young, DO

Family Medicine · Mount Clemens, MINPI 1386027746

Payments from drug & device makers

$295in general payments, 2019–2025

Across 17 payments — averaging $17.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$86
  • AbbVie$55
  • Boehringer Ingelheim$51
  • GSK$38
  • Boston Scientific$29
  • Pfizer$19
  • plus $17 from 1 others

What the payments were for

  • Food & beverage$295100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$295 in reported general payments places this provider in the 50th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$30,847
Medicare patients
113
Services billed
343

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide63$67,634
EliquisApixaban41$48,927
JardianceEmpagliflozin36$39,783
Trelegy ElliptaFluticasone/Umeclidin/Vilanter33$26,719
Spiriva RespimatTiotropium Bromide37$22,747
TrulicityDulaglutide16$21,124
FarxigaDapagliflozin Propanediol18$17,029
TrintellixVortioxetine Hydrobromide20$10,303
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog22$8,870
LinzessLinaclotide13$7,304
GlyxambiEmpagliflozin/Linagliptin11$6,447
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate23$5,704
Atorvastatin Calcium266$3,677
SymbicortBudesonide/Formoterol Fumarate14$3,177
Levothyroxine Sodium239$3,138

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Spiriva Respimat, Glyxambi$51$68,97884 claims
Novo NordiskOzempic$17$67,63463 claims
PfizerEliquis$19$48,92741 claims
GSKTrelegy Ellipta$38$26,71933 claims
AstraZenecaFarxiga, Symbicort$86$20,20632 claims
AbbVieLinzess$55$7,30413 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 3,945 family medicine providers in Michigan.

Other family medicine in Mount Clemens

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →